What is CHSYF stock price today?

Visit our real-time dashboard for the current CHSYF stock price and live market data.

Is CHSYF stock going up or down today?

CHSYF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CHSYF stock now?

The decision to buy CHSYF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CHSYF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CHSYF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CHSYF stock overvalued or undervalued?

CHSYF currently trades at a P/E ratio of 13.50, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if CHSYF is fairly priced.

What is CHSYF's P/E ratio?

CHSYF has a price-to-earnings (P/E) ratio of 13.50, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is CHSYF's market cap?

CHSYF (China Medical System Holdings Limited) has a market capitalization of $3.29 billion, making it a small-cap stock.

What is CHSYF's price to book ratio?

Price-to-book ratio for CHSYF is available on our dashboard along with other valuation metrics.

Does CHSYF pay dividends?

Yes, CHSYF pays dividends with a current yield of 21.63%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is CHSYF's dividend yield?

CHSYF's dividend yield is 21.63%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is CHSYF stock a good long-term investment?

CHSYF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CHSYF's revenue growth rate?

Revenue growth data for CHSYF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CHSYF are available on our dashboard with complete income statement analysis.

What are the risks of investing in CHSYF?

Key risks for CHSYF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CHSYF compare to its competitors?

Compare CHSYF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CHSYF's performance and positioning.

What is CHSYF's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CHSYF with bull, base, and bear case scenarios.

What do analysts say about CHSYF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CHSYF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CHSYF's next earnings report?

CHSYF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CHSYF - China Medical System Holdings Limited

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.00

+$0.00 (+0.00%)

About China Medical System Holdings Limited

China Medical System Holdings Limited (CHSYF) common stock

Price Chart

Loading chart...

CHSYF Key Statistics

Market Cap

$3.29B

P/E Ratio

13.50

Dividend Yield

21.63%

How CHSYF Compares to Peers

CHSYF has the lowest P/E ratio in Drug Manufacturers - Specialty & Generic, suggesting it may be the most undervalued

CHSYF is the smallest among peers, which may offer higher growth potential

P/E Rank

of 3

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 3

Company	Market Cap	P/E	Growth	Margin	Compare
CHSYF(This stock)	$3.29B	13.5	0%	0.0%	-
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: June 15, 2026 at 7:54 AM EDT

Ready to invest in CHSYF?

Commission-free trading available. Affiliate links.

Upcoming Events for CHSYF

Dashboard

Enter a ticker to analyze